Form 4: Orchestra BioMed Holdings Director Hochman Acquires Shares and Options

Director David P. Hochman acquired shares and options in Orchestra BioMed Holdings, Inc. on April 4, 2025, according to a Form 4 filing.

Summary

• On April 4, 2025, David P. Hochman, a director at Orchestra BioMed Holdings, Inc., acquired 98,333 shares of common stock as restricted stock units (RSUs) and 147,500 stock options.
• The RSUs vest over a three-year period, with 33.33% vesting 24 months after the issue date, 33.33% vesting 30 months after the issue date, and 33.34% vesting 36 months after the issue date, contingent upon continuous service.
• The stock options vest starting with 36,875 options on April 4, 2026, and the remaining 110,625 options vesting in equal installments every three months thereafter, also contingent upon continuous service.
• Following the reported transactions, Hochman directly owns 579,498 shares of common stock.
• Hochman also indirectly owns shares through several trusts: 335,002 shares via the DPH 2008 Trust, and 2,000 shares each via the Solomon Ascher Hochman 2019 Trust, the Hannah Hochman 2019 Trust, and the Judah Herman Hochman 2019 Trust, and 3,140 shares via the NSH 2008 Family Trust.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The acquisition of shares and options by a director suggests confidence, but it's a routine filing and doesn't provide substantial information about the company's overall performance.

Positives

• The acquisition of shares and options by a director could be seen as a positive sign, indicating confidence in the company's future prospects.

Future Outlook

The vesting schedules for the RSUs and stock options are contingent upon the Reporting Person's continuous service, suggesting a commitment to the company's future.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC when company insiders, like directors and officers, trade in their company's stock. It provides transparency to the market regarding insider activity.

Stakeholder Impact

• The acquisition of shares by a director could positively influence shareholder sentiment.

Key Dates

Keywords

Orchestra BioMed Holdings, OBIO, Form 4, insider trading, David Hochman, stock options, restricted stock units, RSUs, share acquisition, beneficial ownership